| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/18/2001 | WO2001004311A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2001 | WO2001004310A1 Fc EPSILON RECEPTOR-LUMINESCENCE INDUCING PROTEIN CHIMERIC NUCLEIC ACID MOLECULES, FUSION PROTEINS AND USES THEREOF |
| 01/18/2001 | WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004307A1 Alpha protein - 27 |
| 01/18/2001 | WO2001004306A1 Expression vectors and methods |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004301A1 Fatty acid transporter protein and gene encoding the protein |
| 01/18/2001 | WO2001004300A1 Apoptosis-associated factor |
| 01/18/2001 | WO2001004299A1 AMYLOID β PROTEIN AGGLUTINATION CONTROLLING FACTOR |
| 01/18/2001 | WO2001004298A1 Novel physiologically active substance, process for producing the same and use thereof |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004296A1 Rbp1 polypeptides and uses thereof |
| 01/18/2001 | WO2001004295A1 Orbit and homologues thereof |
| 01/18/2001 | WO2001004294A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | WO2001004293A1 Polypeptides and polynucleotides related to a glycine transporter |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004291A1 Non-lactate-assimilating yeast for improving aerobic stability of silage |
| 01/18/2001 | WO2001004290A1 Triplex-forming oligonucleotides and their use in therapy |
| 01/18/2001 | WO2001004289A1 METHODS AND COMPOSITIONS FOR PRODUCING FULL LENGTH cDNA LIBRARIES |
| 01/18/2001 | WO2001004288A1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 01/18/2001 | WO2001004287A1 A method for preparing modified polypeptides |
| 01/18/2001 | WO2001004286A1 METHOD FOR CONSTRUCTING FULL-LENGTH cDNA LIBRARY |
| 01/18/2001 | WO2001004285A2 Maize msi polynucleotides and methods of use |
| 01/18/2001 | WO2001004282A2 Replication-competent anti-cancer vectors |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004276A1 Cold-active beta galactosidase, the process for its preparation and the use thereof |
| 01/18/2001 | WO2001004274A2 Ketoacyl synthase domains useful for priming of polyketide synthases |
| 01/18/2001 | WO2001004273A2 Glucoamylase variant |
| 01/18/2001 | WO2001004272A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/18/2001 | WO2001004271A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | WO2001004270A1 Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004267A1 One-step allelic exchange in mycobacteria with conditional transducing phage |
| 01/18/2001 | WO2001004266A1 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |
| 01/18/2001 | WO2001004159A1 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 01/18/2001 | WO2001004155A2 Feline interleukin-12 as an immune stimulant |
| 01/18/2001 | WO2001004152A1 Mucin |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004150A2 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004147A2 Plant inositol polyphosphate phosphatase homologs |
| 01/18/2001 | WO2001004146A2 Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| 01/18/2001 | WO2001004144A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 01/18/2001 | WO2001004143A2 Prostase vaccine |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001004136A1 Molecular determinants of tropism and virulence in enteroviruses |
| 01/18/2001 | WO2001004135A2 Crosslinked dna condensate compositions and gene delivery methods |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001003744A2 Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of the c, d or v genes |
| 01/18/2001 | WO2001003743A1 Manipulation of tissue or organ type using the notch pathway |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003730A1 Unmarked deletion mutants of mycobacteria and methods of using same |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003717A2 Methods of inducing cell death |
| 01/18/2001 | WO2001003686A2 Inhibitors of staphylococcus sara protein and their use in treating staphylococcal infections |
| 01/18/2001 | WO2001003501A2 Non-human genetically modified mammal lacking the alpha-fetoprotein |
| 01/18/2001 | WO2000071714A3 Methods of reducing factor viii clearance and compositions therefor |
| 01/18/2001 | WO2000071670A3 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 01/18/2001 | WO2000068383A3 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 01/18/2001 | WO2000066755A3 Pesticidal fusions |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063400A3 Plant transformation process |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000063366A3 Improved antisense oligomers |
| 01/18/2001 | WO2000061786A3 Antisense modulation of pdk-1 expression |
| 01/18/2001 | WO2000061752A3 Modified complement system regulators |
| 01/18/2001 | WO2000060078A3 Latheo encodes a subunit of the origin of recognition complex |
| 01/18/2001 | WO2000060062A3 Human signal transduction serine/threonine protein kinase |
| 01/18/2001 | WO2000060050A3 Recombinant influenza viruses for vaccines and gene therapy |
| 01/18/2001 | WO2000058488A3 Delivery of functional protein sequences by translocating polypeptides |
| 01/18/2001 | WO2000058484A3 Transformation of monocotyledoneous plants using agrobacterium |
| 01/18/2001 | WO2000057904A3 Attenuated dengue-3 virus vaccine |
| 01/18/2001 | WO2000056864A3 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000053794A3 Trait-associated gene identification method |
| 01/18/2001 | WO2000053774A3 Metalloproteinases and methods of use therefor |
| 01/18/2001 | WO2000053760A3 Method of preventing the death of retinal neurons and treating ocular diseases |
| 01/18/2001 | WO2000053744A3 End selection in directed evolution |
| 01/18/2001 | WO2000053213A3 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 01/18/2001 | WO2000047723A3 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same |
| 01/18/2001 | WO2000044497A8 Pipetter |
| 01/18/2001 | WO2000043014A8 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics |
| 01/18/2001 | WO2000023565B1 Novel neuropilin/growth factor binding and uses thereof |
| 01/18/2001 | WO2000022139A3 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |
| 01/18/2001 | WO2000018889A3 Sequenzes of putative plant acyltransferases |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | WO1999051756A3 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 01/18/2001 | WO1999050403A3 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 01/18/2001 | DE19933492A1 Konjugat zur Vermittlung eines zell-, kompartiment- oder membranspezifischen Transports von Wirksubstanzen Conjugate to the presentation of cell-, or compartment-specific membrane transport of active substances |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |
| 01/18/2001 | DE19933024A1 Kationische Blockcopolymere Cationic block copolymers |